右美托咪定对30例体外循环患者肠道屏障损伤的影响

doi:10.6040/j.issn.1671-7554.0.2022.0296

摘要/Abstract

摘要： 目的探讨右美托咪定(DEX)对体外循环患者肠道屏障损伤的影响。方法将60例行体外循环心脏手术患者随机分为DEX组和对照组,每组30例。DEX组给予DEX干预,对照组给予等容量生理盐水输注。每组于给药前(T0)、体外循环结束即刻(T1)、术后2 h(T2)、术后6 h(T3)、术后24 h(T4)采集静脉血,测定肠型脂肪酸结合蛋白(I-FABP)、内毒素(LPS)、白介素-6(IL-6)及白介素-10(IL-10)浓度。并记录两组患者术后首次排便时间、重症监护室驻留时间、住院时间、死亡率以及不良反应的发生。结果 60例患者均完成了研究方案,未观察到死亡或严重并发症。同一组不同时间点血清I-FABP、LPS、IL-6、IL-10浓度差异具有统计学意义(P均<0.001),T1~T4点均较T0点高。两组间血清I-FABP、LPS、IL-6、IL-10浓度差异具有统计学意义(P=0.029;P=0.002;P=0.022;P=0.022);DEX组T1~T4点I-FABP、LPS、IL-6较对照组低,IL-10水平较对照组高。两组患者术后第一次排便时间、ICU驻留时间、住院时间差异无统计学意义(P均>0.05)。结论 DEX能够减轻体外循环患者肠道屏障的损伤。

关键词: 体外循环, 右美托咪定, 肠道屏障功能, 内毒性血症, 炎症反应

Abstract: Objective To investigate the effects of dexmedetomidine(DEX)on the intestinal barrier injury in patients with cardiopulmonary bypass. Methods A total of 60 patients undergoing cardiopulmonary bypass cardiac surgery were randomly divided into DEX group(n=30)and control group(n=30). The DEX group was given DEX intervention and the control group was given saline infusion of the same volume. Venous blood samples were collected before administration(T0), immediately after cardiopulmonary bypass(T1), 2 hours after operation(T2), 6 hours after operation(T3)and 24 hours after operation(T4). The levels of intestinal fatty acid binding protein(I-FABP), endotoxin(LPS), interleukin-6(IL-6)and interleukin-10(IL-10)were measured. The first defecation time, intensive care unit stay time, hospital stay, mortality and adverse reactions of the two groups were recorded. Results All 60 patients completed the study protocol, and no death or serious complications were observed. The levels of serum I-FABP, LPS, IL-6 and IL-10 in either group at different time points were significantly different(P<0.001), and the levels at T1-T4 were higher than those at T0. The levels of serum I-FABP, LPS, IL-6 and IL-10 were significantly different between the two groups(P=0.029; P=0.002; P=0.022; P=0.022), and the levels of I-FABP, LPS, IL-6 in DEX group at T1-T4 were lower than those in control group, but the levels of IL-10 were higher than those in control group. There were no significant differences in the first defecation time, ICU stay time and hospital stay between the two groups(P>0.05). Conclusion DEX can alleviate the damage of intestinal barrier in patients with cardiopulmonary bypass.

Key words: Cardiopulmonary bypass, Dexmedetomidine, Gut barrier function, Endotoxemia, Inflammation

中图分类号:

R614

李锐,石存现,于翠翠. 右美托咪定对30例体外循环患者肠道屏障损伤的影响[J]. 山东大学学报 (医学版), 2022, 60(7): 83-88.

LI Rui, SHI Cunxian, YU Cuicui. Effects of dexmedetomidine on intestinal-related injury during cardiopulmonary bypass[J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 83-88.

参考文献

[1] Featherstone PJ, Ball CM. The origins of cardiopulmonary bypass [J]. Anaesth Intensive Care, 2018, 46(4): 351-353.
[2] Akhtar MI, Gautel L, Lomivorotov V, et al. Multicenter international survey on cardiopulmonary bypass perfusion practices in adult cardiac surgery [J]. J Cardiothorac Vasc Anesth, 2021, 35(4): 1115-1124.
[3] Justus G, Walker C, Rosenthal LM, et al. Immunodepression after CPB: Cytokine dynamics and clinics after pediatric cardiac surgery- A prospective trial [J]. Cytokine, 2019, 122: 154018. doi: 10. 1016/j. cyto. 2017. 03. 017.
[4] Tsukamoto H, Takeuchi S, Kubota K, et al. Lipopolysaccharide(LPS)-binding protein stimulates CD14-dependent toll-like receptor 4 internalization and lps-induced tbk1-ikk-irf3 axis activation [J]. J Biol Chem, 2018, 93(26): 10186-10201.
[5] Hadley JS, Wang JE, Michaels LC, et al. Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass [J]. Shock, 2007, 27(5): 466-473.
[6] Zhang GR, Peng CM, Liu ZZ, et al. The effect of dexmedetomidine on myocardial ischemia/reperfusion injury in patients undergoing cardiac surgery with cardiopulmonary bypass: a meta-analysis [J]. Eur Rev Med Pharmacol Sci, 2021, 25(23): 7409-7417.
[7] Unchiti K, Leurcharusmee P, Samerchua A, et al. The potential role of dexmedetomidine on neuroprotection and its possible mechanisms: evidence from in vitro and in vivo studies [J]. Eur J Neurosci, 2021, 54(9): 7006-7047.
[8] Yang J, Wu Y, Xu Y, et al. Dexmedetomidine resists intestinal ischemia-reperfusion injury by inhibiting TLR4/MyD88/NF-κB signaling [J]. J Surg Res, 2021, 260: 350-358. doi: 10. 1016/j. jss. 2020. 11. 041.
[9] Sun W, Li F, Wang X, et al. Effects of dexmedetomidine on patients undergoing laparoscopic surgery for colorectal cancer[J]. J Surg Res, 2021, 267: 687-694. doi: 10. 1016/j. jss. 2021. 06. 043.
[10] 刘浩, 鲁金钢, 赵鹏程, 等. 右美托咪定预处理对老年腹腔镜手术患者术后氧化应激水平及肠屏障功能的影响[J]. 中华全科医学, 2020, 8(4): 585-588 LIU Hao, LU Jingang, ZHAO Pengcheng, et al. Effects of dexmedetomidine preconditioning on postoperative oxidative stress and intestinal barrier function in elderly patients undergoing laparoscopy [J]. Zhonghua General Medicine, 2020, 8(4): 585-588.
[11] Druml W. Intestinal cross-talk: The gut as motor of multiple organ failure [J]. Med Klin Intensivmed Notfmed, 2018, 113(6): 470-477.
[12] Hess NR, Seese LM, Hong Y, et al. Gastrointestinal complications after cardiac surgery: Incidence, predictors, and impact on outcomes [J]. J Card Surg, 2021, 36(3): 894-901.
[13] Zenger S, Demir Piroglu I, Çevik A, et al. The importance of serum intestinal fatty acid-binding protein for the early diagnosis of acute mesenteric ischemia [J]. Ulus Travma Acil Cerrahi Derg, 2021, 27(3): 278-283.
[14] Su W, Li Y, Wang Y, et al. Correlation between 1-FABP, blood routine and grading of necrotising enterocolitis [J]. J Coll Physicians Surg Pak, 2021, 31(2): 238-239.
[15] Kong C, Li SM, Yang H, et al. Screening and combining serum biomarkers to improve their diagnostic performance in the detection of intestinal barrier dysfunction in patients after major abdominal surgery [J]. Ann Transl Med, 2019, 7(16): 388. doi: 10. 21037/atm. 2019. 07. 102.
[16] Nuzzo A, Guedj K, Curac S, et al. Accuracy of citrulline, I-FABP and D-lactate in the diagnosis of acute mesenteric ischemia [J]. Sci Rep, 2021, 11(1): 18929. doi: 10. 1038/s41598-021-98012-w.
[17] Brandenburg K, Schromm AB, Weindl G, et al. An update on endotoxin neutralization strategies in gram-negative bacterial infections [J]. Expert Rev Anti Infect Ther, 2021, 19(4): 495-517.
[18] Adamik B, Kübler A, Gozdzik A, et al. Prolonged cardiopulmonary bypass is a risk factor for intestinal ischaemic damage and endotoxaemia [J]. Heart Lung Circ, 2017, 26(7): 717-723.
[19] Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling [J]. Cell Mol Life Sci, 2021, 78(4): 1233-1261.
[20] Dong N, Li X, Xue C, et al. Astragalus polysaccharides alleviates LPS-induced inflammation via the NF-κB/MAPK signaling pathway [J]. J Cell Physiol, 2020, 235(7-8): 5525-5540.
[21] Uciechowski P, Dempke WCM. Interleukin-6: a masterplayer in the cytokine network [J]. Oncology, 2020, 98(3): 131-137.
[22] Fernandez-Santamaria R, Satitsuksanoa P. Engineered IL-10: A matter of affinity [J]. Allergy, 2022, 77(3): 1067-1069.
[23] Jia T, Xing Z, WangAnd H, et al. Protective effect of dexmedetomidine on intestinal mucosal barrier function in rats after cardiopulmonary bypass [J]. Exp Biol Med(Maywood), 2022, 247(6): 498-508.
[24] Pan S, Chen Y, Zhang X, et al. The JAK2/STAT3 pathway is involved in dexmedetomidine-induced myocardial protection in rats undergoing cardiopulmonary bypass [J]. Ann Transl Med, 2020, 8(7): 483. doi: 10.21037/atm.2020.03.67.
[25] Li J, Dou X, Li D, et al. Dexmedetomidine ameliorates post-cpb lung injury in rats by activating the PI3K/Akt pathway [J]. J Invest Surg, 2020, 33(6): 576-583.
[26] Aydin C, Bagcivan I, Gursoy S,et al. Altered spontaneous contractions of the ileum by anesthetic agents in rats exposed to peritonitis [J]. World J Gastroenterol, 2009, 15(13): 1620-1624.

相关文章 15

[1]	贾若曦,吕丽,刘涵云,吴寅平,李凤彩,赵泽华,王凯,范玉琛. 血细胞计数相关标志物对慢加急性乙型肝炎肝衰竭患者28天预后的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(6): 89-99.
[2]	杜艾家,张曼,陈鹤,王丽新,尚应殊. 微小RNA-1270靶向调控血管生成素样蛋白7抑制巨噬细胞炎症和脂质蓄积[J]. 山东大学学报 (医学版), 2025, 63(2): 1-9.
[3]	管伟,白云峰,杜胜杰,王月兰,李希明. 基于RNA高通量测序研究右美托咪定对人神经母细胞瘤细胞基因表达的影响[J]. 山东大学学报 (医学版), 2023, 61(7): 27-33.
[4]	杨元凤,熊高才,黎豫川,罗玉玲,张敬杰. 鹿苓安肾颗粒对慢性肾功能衰竭大鼠炎症反应及细胞凋亡的影响[J]. 山东大学学报 (医学版), 2023, 61(10): 9-16.
[5]	周溪,黄霂晗,任玉洁,邱洋. 新型冠状病毒感染与天然免疫及炎症反应[J]. 山东大学学报 (医学版), 2021, 59(5): 15-21.
[6]	闵傲雪,朱天瑞,张凤,王冉冉,李晓红. A151对糖氧剥夺和脂多糖诱导的BV-2细胞极化的影响[J]. 山东大学学报 (医学版), 2021, 59(3): 1-9.
[7]	杨佳,张曼,陈凯明,曹曦. miR-146a经TLR4/MyD88途径加速巨噬细胞迁移所致动脉硬化的作用机制[J]. 山东大学学报 (医学版), 2021, 59(11): 1-7.
[8]	高金梅,黄映波,冯珍珍. 单核细胞趋化蛋白-1对67例全身炎症反应综合征患者的诊断价值[J]. 山东大学学报 (医学版), 2021, 59(10): 77-81.
[9]	车东阳,厉泉,陈善良,于建民,李敏,许莉,毕严斌,李培杰,刘天起. 心脏移植围术期右心功能不全与肺血管阻力的关系及处理[J]. 山东大学学报 (医学版), 2019, 57(5): 99-104.
[10]	郭配,李秀华,张晓韬,何天齐,朱梅佳,唐吉友,赵张宁,毛飞. 伴有睡眠障碍帕金森病患者的睡眠特征及其影响因素[J]. 山东大学学报 (医学版), 2018, 56(4): 76-80.
[11]	陈攀,蒋春霞,雷艺. 2型糖尿病患者外周血突触融合蛋白8表达与慢性炎症、糖脂代谢的相关性[J]. 山东大学学报 (医学版), 2018, 56(12): 26-32.
[12]	张栾,陈欧,栾云,朱晓波,陈元,王一彪. Gemigliptin对野百合碱诱导的肺动脉高压大鼠治疗作用及炎症因子的影响[J]. 山东大学学报（医学版）, 2017, 55(5): 19-22.
[13]	孙鹏飞,孟晓,张凯,黎莉. 抵抗素样分子 β在动脉粥样硬化斑块稳定性中的作用[J]. 山东大学学报（医学版）, 2016, 54(3): 1-4.
[14]	李少伟, 刘宗正, 刘春霞, 张焱如, 周欢敏. 葡萄籽原花青素对小鼠脂肪肝模型缺血再灌注造成的急性肝损伤的保护作用[J]. 山东大学学报（医学版）, 2015, 53(9): 41-46.
[15]	韩潇, 刘锟, 史加海, 高福民, 尤庆生. 醒脑静在体外循环心脏手术中对脑功能的保护[J]. 山东大学学报（医学版）, 2015, 53(1): 54-57.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed